Detalhe da pesquisa
1.
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Ann Oncol
; 34(3): 289-299, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494006
2.
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.
Ann Oncol
; 24(9): 2409-14, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788753